Amarin Corp Plc (AMRN)

[ggwpq]

Factors that point to R-I trial success :

1) JELIS
2) ACCORD and AIM-HIGH subgroups analysis
3) Latest US and European APOc3 research

Pls. add anything you can think of.


Factors that point to R-I trial failure :

1) trial data gathering screw up
2) trial under-powered which led to time extension


Pls. add anything you can think of.

At this point, probability of R-I trial success is at least 50%, IMHO. Hence, the expected value of a multi-billion dollar drug like Vascepa is at least couple billions, no?